Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Journal of Cutaneous Pathology
|
October 11, 2015
Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation
William T Johnson, Parth Patel, Amanda Hernandez, et al.
Blood Advances
|
April 9, 2024
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma
Ying Liu, Rohan Sardana, David Nemirovsky, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare
|
March 28, 2023
Development and Validation of a Mixed-Reality Simulator for Reducing Biopsy Core Deviation During Simulated Freehand Systematic Prostate Biopsy
Samsun Lampotang, David E Lizdas, William T Johnson, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Blood Advances
|
March 29, 2023
Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms
Colleen Isabelle, William T Johnson, Kathleen McConnell, et al.
BJU International
|
May 7, 2021
Attitude is everything: keep probe pitch neutral during side-fire prostate biopsy. A simulator study
Zhou Zhang, Samsun Lampotang, Yichao Yu, et al.
Haematologica
|
June 11, 2026
Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns
Robert Stuver, Zachary R Moore, Stefan K Barta, et al.
Diabetes
|
March 28, 2002
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models
Garret J Etgen, Brian A Oldham, William T Johnson, et al.
Haematologica
|
May 16, 2024
Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis
William T Johnson, Zachary D Epstein-Peterson, Nivetha Ganesan, et al.
Blood Advances
|
June 12, 2023
Retrospective characterization of nodal marginal zone lymphoma
Robert Stuver, Esther Drill, David Qualls, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Journal of Cutaneous Pathology
|
October 11, 2015
Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation
William T Johnson, Parth Patel, Amanda Hernandez, et al.
Blood Advances
|
April 9, 2024
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma
Ying Liu, Rohan Sardana, David Nemirovsky, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare
|
March 28, 2023
Development and Validation of a Mixed-Reality Simulator for Reducing Biopsy Core Deviation During Simulated Freehand Systematic Prostate Biopsy
Samsun Lampotang, David E Lizdas, William T Johnson, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Blood Advances
|
March 29, 2023
Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms
Colleen Isabelle, William T Johnson, Kathleen McConnell, et al.
BJU International
|
May 7, 2021
Attitude is everything: keep probe pitch neutral during side-fire prostate biopsy. A simulator study
Zhou Zhang, Samsun Lampotang, Yichao Yu, et al.
Haematologica
|
June 11, 2026
Outcomes in early stage peripheral T-cell lymphoma by stage, histology, and treatment patterns
Robert Stuver, Zachary R Moore, Stefan K Barta, et al.
Diabetes
|
March 28, 2002
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models
Garret J Etgen, Brian A Oldham, William T Johnson, et al.
Haematologica
|
May 16, 2024
Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis
William T Johnson, Zachary D Epstein-Peterson, Nivetha Ganesan, et al.
Blood Advances
|
June 12, 2023
Retrospective characterization of nodal marginal zone lymphoma
Robert Stuver, Esther Drill, David Qualls, et al.
Page
of 5